Caribou Biosciences, Inc. · Hybrid, Berkeley, Remote, Country not listed
· Posted 2026-09-16
Caribou Biosciences is a leading clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. Our next-generation genome-editing technology enables superior precision to develop cell therapies that are armored to potentially impr
MedicalDirectorclinicalothercariboudevelopmentcellleading
Caribou Biosciences, Inc. · Hybrid, Berkeley, Remote, Country not listed
· Posted 2026-09-15
Caribou Biosciences is a leading clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. Our next-generation genome-editing technology enables superior precision to develop cell therapies that are armored to potentially impr
MedicalScienceLiaisonMSLFieldcaribouclinicaltherapy
Caribou Biosciences, Inc. · Hybrid, Berkeley, Remote, Country not listed
· Posted 2026-09-14
· 5+ years
Caribou Biosciences is a leading clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. Our next-generation genome-editing technology enables superior precision to develop cell therapies that are armored to potentially impr
ClinicalBiomarkersbiomarkercariboucelltherapytranslationalresearch
Caribou Biosciences, Inc. · Hybrid, Berkeley, Remote, Country not listed
· Posted 2026-08-05
· 6+ years
Caribou Biosciences is a leading clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. Our next-generation genome-editing technology enables superior precision to develop cell therapies that are armored to potentially impr
GCPExcel
Caribou Biosciences, Inc. · Multiple Locations, Country not listed
· Posted 2024-08-23
Caribou Biosciences is a leading clinical-stage CRISPR genome-editing biopharmaceutical company, dedicated to developing transformative therapies for patients with devastating diseases. Our next-generation genome-editing technology delivers unmatched precision, enabling us to develop cell therapies that are designed to
Express